Manufacturing And Sustainability

  1. Nunc Standard Closed Cell Factory System 2/2/2022

    This clean and closed system is designed to provide consistent and high-quality results to enhance your adherent cell culture processes. This ready-to-use system will help you quickly develop and scale up your processes with standard components for supply assurance.

  2. Animal Testing & Tox: What's Required Today? 2/21/2023

    In this segment of the Bioprocess Online Live event IND Success: Navigate Through The Regulatory Gray, Umoja Biopharma VP of Regulatory Affairs Heln Kim entertains audience questions on FDA toxicology and animal study requirements in light of the Reducing Animal Testing Act passed in December, 2022.

  3. Digital Design Meets Proven Performance: The Future Of Single-Use Assemblies 3/31/2026

    Single-use assembly design is evolving fast. Learn how scalable platforms, digital automation tools, and global supply networks are converging to support sustainable biopharma manufacturing at scale.

  4. Advances In Flow-Through Technology To Enhance mAb Polishing 5/27/2025

    Walk through three case studies that illustrate how novel chromatographic tools can improve the purification process for complex therapeutics by reducing aggregates and HCPs and effectively clearing retroviruses.

  5. mAb Up- And Downstream Process Intensification Strategies 12/12/2024

    Discover how to reduce monoclonal antibody (mAb) manufacturing time and costs through process intensification. Learn about continuous perfusion, ultrahigh cell density banks, and more.

  6. Planning For Success: Supply Resiliency Strategies For Bench To Production 10/18/2023

    Build scalable material sourcing strategies for R&D and early phases through to commercialization and learn how to accelerate the development process and ensure the scalability of your biologics.

  7. Addressing Post-Translational Modifications In Novel Protein Therapeutics 9/13/2024

    Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech, addresses an audience question on conjugation efficiencies in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics. From there, we move on to an audience-led discussion on when to initially address titer, PTMS, and product quality during development of novel protein therapeutic cell lines, with Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics weighing in.

  8. HyPerforma 5:1 Single-Use Bioreactor (S.U.B.) Setup And Installation Part 2 5/7/2020

    This video is part 2 of 3 videos that cover setup and installation topics related to the HyPerforma 5:1 Single-Use Bioreactor, or S.U.B. In this video we will cover initial BioProcess Container, or BPC, loading, drive shaft insertion, final installation steps.

  9. A Collaboration With Fresenius Kabi BioPharm 5/19/2025

    Explore how biosimilar development is advancing through collaboration, innovative cell culture strategies, and the use of advanced media to meet biomanufacturing goals.

  10. Why Clinical Holds Happen 2/21/2023

    The volume of clinical holds doled out by the FDA has skyrocketed in recent years. In this segment of the Bioprocess Online Live event IND Success: Navigate Through The Regulatory Gray, NDA Partners Expert Consultant Daniela Drago, Ph.D. and Umoja Biopharma VP of Regulatory Affairs Helen Kim explain clinical holds and discuss why they happen.